Updates

Tweets by @cellcentric

All our updates and events through tweets

Delighted to announce $33m of further funding; continuing to progress our first-in-class p300/CBP inhibitor CCS1477, in clinical trials for multiple cancer applications. pic.twitter.com/pzxlzz2mmd

Neil and Nigel (virtually) at the always excellent Prostate Cancer Foundation Retreat over the next 3 days. pic.twitter.com/NjVknIyWW0

Great to have another site open as we expand clinical testing of our first-in-class p300/CBP inhibitor. Edinburgh; haem malignancies. pic.twitter.com/HfC6vJsy4A

Stay up to date with Cellcentric and follow us on twitter

Follow us

Fabulous to have Tahira joining the team, as CellCentric looks to expand its clinical trials of CCS1477, including into Europe in 2021. pic.twitter.com/G7EGI9F3ED

Another site active; CellCentric’s CCS1477 haematology clinical programme. Many thanks to Paresh Vyas and the team at Oxford. pic.twitter.com/eeiFw5nMDK

CellCentric one of the ambassador co’s for UK biotech sector today at Parliament. Turning world leading research into novel healthcare products. @BIA_UK pic.twitter.com/D7wooMQobQ